Induction of recurrent break cluster genes in neural progenitor cells differentiated from embryonic stem cells in culture.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
12 05 2020
Historique:
pubmed: 26 4 2020
medline: 22 8 2020
entrez: 26 4 2020
Statut: ppublish

Résumé

Mild replication stress enhances appearance of dozens of robust recurrent genomic break clusters, termed RDCs, in cultured primary mouse neural stem and progenitor cells (NSPCs). Robust RDCs occur within genes ("RDC-genes") that are long and have roles in neural cell communications and/or have been implicated in neuropsychiatric diseases or cancer. We sought to develop an in vitro approach to determine whether specific RDC formation is associated with neural development. For this purpose, we adapted a system to induce neural progenitor cell (NPC) development from mouse embryonic stem cell (ESC) lines deficient for XRCC4 plus p53, a genotype that enhances DNA double-strand break (DSB) persistence to enhance detection. We tested for RDCs by our genome-wide DSB identification approach that captures DSBs via their ability to join to specific genomic Cas9/single-guide RNA-generated bait DSBs. In XRCC4/p53-deficient ESCs, we detected seven RDCs, all of which were in genes and two of which were robust. In contrast, in NPCs derived from these ESC lines we detected 29 RDCs, a large fraction of which were robust and associated with long, transcribed neural genes that were also robust RDC-genes in primary NSPCs. These studies suggest that many RDCs present in NSPCs are developmentally influenced to occur in this cell type and indicate that induced development of NPCs from ESCs provides an approach to rapidly elucidate mechanistic aspects of NPC RDC formation.

Identifiants

pubmed: 32332169
pii: 1922299117
doi: 10.1073/pnas.1922299117
pmc: PMC7229678
doi:

Substances chimiques

DNA-Binding Proteins 0
XRCC4 protein, human 0
XRCC4 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10541-10546

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Mol Cell. 2011 Dec 23;44(6):966-77
pubmed: 22195969
Nat Commun. 2018 Nov 12;9(1):4760
pubmed: 30420702
Nature. 1998 Nov 12;396(6707):173-7
pubmed: 9823897
Nat Struct Mol Biol. 2011 Nov 06;18(12):1421-3
pubmed: 22056772
Cell. 2014 Dec 18;159(7):1538-48
pubmed: 25483776
Cell. 2012 Mar 2;148(5):908-21
pubmed: 22341456
Nature. 2018 Nov;563(7729):126-130
pubmed: 30305734
Cell Stem Cell. 2020 Feb 6;26(2):221-233.e6
pubmed: 32004479
Genes Dev. 2001 Dec 15;15(24):3237-42
pubmed: 11751629
Cell. 2013 Jan 31;152(3):417-29
pubmed: 23374339
Trends Neurosci. 2000 Mar;23(3):100-5
pubmed: 10675909
Nature. 2016 Apr 7;532(7597):46-7
pubmed: 27007850
PLoS Genet. 2012 Sep;8(9):e1002981
pubmed: 23028374
Annu Rev Genet. 2013;47:1-32
pubmed: 23909437
Cell. 1998 Dec 23;95(7):891-902
pubmed: 9875844
Genome Res. 2015 Feb;25(2):189-200
pubmed: 25373142
Curr Biol. 1998 Dec 17-31;8(25):1395-8
pubmed: 9889105
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7378-83
pubmed: 16670198
Nature. 2000 Apr 20;404(6780):897-900
pubmed: 10786799
Am J Hum Genet. 2009 Mar;84(3):339-50
pubmed: 19232554
Nat Biotechnol. 2003 Feb;21(2):183-6
pubmed: 12524553
Science. 2017 Apr 28;356(6336):
pubmed: 28450582
Cell. 2016 Feb 11;164(4):593-5
pubmed: 26871622
Cell. 2016 Feb 11;164(4):644-55
pubmed: 26871630
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1919-1924
pubmed: 29432181
Nat Protoc. 2016 May;11(5):853-71
pubmed: 27031497
Stem Cells Dev. 2010 Nov;19(11):1699-711
pubmed: 20446816
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714
pubmed: 31263220
Mol Cell. 2000 Jun;5(6):993-1002
pubmed: 10911993

Auteurs

Aseda Tena (A)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Department of Genetics, Harvard Medical School, Boston, MA 02115.
Biological and Biomedical Sciences PhD Program, Harvard University, Boston, MA 02115.

Yuxiang Zhang (Y)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Department of Genetics, Harvard Medical School, Boston, MA 02115.
Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.

Nia Kyritsis (N)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Anne Devorak (A)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Jeffrey Zurita (J)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Pei-Chi Wei (PC)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115; p.wei@dkfz-heidelberg.de alt@enders.tch.harvard.edu.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Frederick W Alt (FW)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115; p.wei@dkfz-heidelberg.de alt@enders.tch.harvard.edu.
Department of Genetics, Harvard Medical School, Boston, MA 02115.
Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH